HMGB1 and keratitis: When we tested the two agents in the keratitis model [4], GLY was better overall in decreasing HMGB1 expression (mRNA and protein) in KEI 1025 (a clinical isolate of P. aeruginosa)–infected corneas and decreased corneal disease better when compared with carbenoxolone.